MyMeta Force in Complete Omics
MyMeta Force in Complete Omics - Metabolomics Department in COMyMeta Force in Complete OmicsMyMeta Force in Complete OmicsMyMeta Force in Complete Omics

Metabolomics Department in CO

  • Telphone: [USA] +1-410-215-2760
  • Email: info@completeomics.com
CONSULTATION
  • Home
  • People
    • Our Team
    • Our Collaborators
  • Clinical Tests
  • Unique Services
    • Hot Pipelines
      ☑Flux Metabolomics
      ☑Immunometabolomics
      ☑Oncometabolomics
      ☑Anti-tumor Drug
      ☑Toxicology and Others
      ☑Complex Data Analysis
    • Single Cell Metabolomics
      handled by our Single Cell Omics team
    • Customized multi-omics
      please visit our headquarter website
  • Panels
    • Targeted Pathway Panels
      • Amino Acids
      • Bile Acids
      • Cannabinoids
      • Central Carbons
      • Complex Lipids
      • Fatty Acids
      • Metal Analysis
      • Oxysterols
      • Short Chain Fatty Acids
    • Targeted Disease Panels
      • Diabetes Markers
      • Impaired Glucose Tolerance Markers
      • Indoles/Uremic Toxicity Markers
      • Insulin Resistance Markers
    • Targeted Single Analyte
  • Publications
    • Flux Direction
    • Targeted
    • Untargeted
    • Multi-Omics
  • News
    • News at Complete Omics Inc.
  • Contacts

Yearly Archives: 2018

MyMeta Force in Complete Omics > Blog Large Image > 2018
18
Feb
Date February 18, 2018
Author MyMeta Force

An engineered IL-2 partial agonist promotes CD8+ T cell stemness.

We provide complete process piping capabilities for industrial from pulp and paper.
Read More
0 Comments Author MyMeta Force
21
Jan
Date January 21, 2018
Author MyMeta Force

GOT1 constrains TH17 cell differentiation, while promoting iTreg cell differentiation

We provide complete process piping capabilities for industrial from pulp and paper.
Read More
0 Comments Author MyMeta Force

Categories

  • Chemistry
  • Forensic science
  • Gemological
  • Scientific

Recent Posts

  • Divergent metabolic programs in tumor immune evasionNovember 22, 2019
  • An engineered IL-2 partial agonist promotes CD8+ T cell stemness.February 18, 2018
  • GOT1 constrains TH17 cell differentiation, while promoting iTreg cell differentiationJanuary 21, 2018
  • Persistent CAD activity in memory CD8+ T cells supports rRNA synthesis and ribosomal biogenesis required at rechallenge.September 29, 2017
  • Phosphoinositide acyl chain saturation drives CD8+ effector T cell signaling and functionSeptember 27, 2017

Tags

Biochemistry research Chemistry equipment‎ Medical Physics scientific research

Archives

  • November 2019
  • February 2018
  • January 2018
  • September 2017
  • August 2017
Precision Metabolomics for Comprehensive Clinical Omics Solutions.

USEFUL LINKS

  • About Us
  • Our Services
  • Our Team
  • Contacts
  • Research

OUR SERVICES

  • Scientific
  • Chemistry
  • Gemological
  • Forensic science
  • Immunology

RECENT POST

  • Divergent metabolic programs in tumor immune evasion November 22, 2019
  • An engineered IL-2 partial agonist promotes CD8+ T cell stemness. February 18, 2018
Copyright © 2025 Complete Omics. All rights reserved.